A vaccine targeting mutant IDH1 in newly diagnosed glioma

Nature, Published online: 24 March 2021; doi:10.1038/s41586-021-03363-z

A phase 1 clinical trial provides evidence that a vaccine against mutant IDH1 is safe and produces a T helper immune response in patients with glioma.

Comments

Popular posts from this blog

Photo Of The Day By Valerie Millett